Final Flashcards
OXT
synthesized by magnocellular neurons, released through post. pituitary into general circulation
mech. stim (↑ pressure of cervix/myometrial contractions/suckling stim) triggers secretion from pituitary → stimulates OXT Rs in uterus/smooth m. of milk ducts in mammary glands = ↑ contraction
positive feedback: mechanoreceptors send impulses to hypot = ↑ OXT
also bonding effect
vasopressin
synthesized by magnocellular neurons, released through post. pituitary into general circulation
↑ blood osmolarity/↓bp/↓blood vol triggers secretion from pituitary
kidneys: insertion of aq-2 channels = ↑ water reabsorption
vasculature: vasoconstriction
anterior pituitary: ACTH release
inhibited by alcohol
GH
pulsatile release from somatotrophs in anterior pituitary
bone: induces growth (postnatal)
muscle: ↑ aa uptake
adipocytes: ↑ lipolysis + ↓ body fat
liver: secretion of IGF-1
therapeutic use: replacement therapy - inj
tx of pituitary dwarfism + adult GH deficiency, short stature of Turner’s syndrome
GH regulators
GHRH: positive central regulator = ↑ gene expr, ↑ GH release, induces somatotroph growth
STT: neg central regulator = ↓ GH release
ghrelin: pos peripheral reg = ↑ GH release from somatotrophs, ↑ GHRH + ↓ STT
IGF-1: neg peripheral reg = ↓ GHRH + ↑ STT, ↓ GH release
GH: autocrine factor - neg feedback
pegvisomant
recombinant GH antagonist
tx of acromegaly
octreotide
STT receptor agonist
tx of acromegaly + gigantism
cortisol
circadian rhythm/stress induce hypot. release of CRH → corticotrophs = release of ACTH → synthesis of cholesterol in adrenal cortex = ↑ cortisol
negative feedback = inhibit CRH + ACTH → terminate stress response
bound to CBG (+ albumin) = inactive
inactivated by 11βHSD2 in kidney to cortisone; reactivated by 11βHSD1 in liver
release from CBG - cross cell membrane - binds GR → translocation to nucleus → dimerizes = genomic effects (transactivation or transrepression)
17α hydroxylase
metabolism of pregnenolone in z. fasciculata + reticularis = involved in cortisol + androgen synthesis
inhibited by ketoconazole in tx of Cushings and prostate cancer
21β hydroxylase
metabolism of pregnenolone in z. fasciculata + glomerulus = involved in cortisol + aldosterone synthesis
genetic mutation or immune response = primary adrenal insufficiency
11β hydroxylase
metabolism of pregnenolone in z. fasciculata + glomerulus = involved in cortisol + aldosterone synthesis
inhibited by metyrapone = tx of cushings
hydrocortisone
glucocorticoid replacement therapy
fails to replicate circadian rhythym of cortisol secretion
Chronocort = better mimic → tx for congenital adrenal hyperplasia
prednisone
4x ↑ potency = greater affinity for GR receptor than cortisol
dexamethasone
30x ↑ potency = greater affinity for GR receptor (no MR interaction
vamolorone
selective glucocorticoid receptor modulator
favours transrepressing actions (anti-infl) of GR over transactivating (side effects)
ketoconazole
antifungal, inhibitor of 17α hydroxylase
tx of Cushing’s disease - ↓ synthesis of cortisol + androgens
side effects: ↑ P and aldosterone
metyrapone
inhibitor of 11β hydroxylase = ↓ cortisol + aldosterone
tx of Cushing’s disease
side effects: chronic use may cause hirsutism + hypertension
mifepristone
GC antagonist (high affinity for GR)
tx of inoperable patients with ectopic ACTH secretion or adrenal carcinoma
SPRM: selective P antagonist → ↓ embryo implantation
emergency contraception - single dose in late follicular phase inhibits LH surge = no ovulation
combined with misoprostol = medical 1st trimester abortion
estrogen
converted from androstenedione by aromatases
promote females sex development, growth, + endometrial proliferation
↑ binding proteins, ↑ HDL, ↓ LDL, kidney: salt + water retention
therapeutic uses: replacement therapy, contraception, menopause
adverse effects: ↑ cancer risk (breast, endometrial), thrombosis, edema
anastrozole
antiestrogen = inhibitor of aromatase → ↓ E synthesis
tx of early + advanced ER+ reast cancer in postmenopausal women
no ↑ risk for uterine cancer or thrombosis
clomiphene citrate
SERM → blocks ERs in hypot. + pit. - no negative feedback = ↑ gonadotropins
tx: induce ovulation, infertility, amenorrhea, PCOS
adverse effects: ovarian cysts, hot flashes, multiple births
tamoxifen
SERM, prodrug (CYP2D6 → endoxifen)
combined with SSRIs (↓ CYP2D6) to ↓ hot flashes
tx of breast cancer; osteoporotic
adverse effects: ↑ risk of uterine cancer, blood clots
raloxifen
SERM = neutral in uterine tissue = no ↑ risk of cancer
still risk of blood clots
fulvestrant
SERD → binds ER monomer + prevents dimerization = degradation through ubiquitin pathway
tx of metastatic ER+ breast cancer
inhibits growth of tamoxifen-resistant tumors
PROTACs
proteolysis targeting chimeras = bind ER + E3 ligase = induce ubiquitination → degradation of ER
tx of ER+ breast cancer